Alzamend Neuro Inc (ALZN)
$1.34+0.00%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 0.19
- P/E (TTM)
- -0.60
- Short % float
- 3.67%
- Days to cover
- 1.1
- SI change
- -9.3%
- 1W
- -2.19%
- 1M
- -21.18%
- vs SPY 1W
- -3.35%
- vs SPY 1M
- -24.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on ALZN?
- LOPJLB’s latest quantitative signal on Alzamend Neuro Inc (ALZN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ALZN in?
- Alzamend Neuro Inc (ALZN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Alzamend Neuro Inc (ALZN) do?
- Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other ne…